Hanninen, M., Venner, P. and North, S. 2013. A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer. Canadian Urological Association Journal. 3, 5 (May 2013), 369–74. DOI:https://doi.org/10.5489/cuaj.1145.